KEN NAKASONE

HONOLULU, HI NPI 1508929431

General Payments — all program years on this page

$4,553.60

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 239
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $466.98 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.9820

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,077.2463
2019 $997.7155
2020 $813.3543
2021 $673.2530
2022 $525.0728
2023 $466.9820

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1000000317 Bayer Healthcare Pharmaceuticals Inc. $17.65 05/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000005059 Bayer Healthcare Pharmaceuticals Inc. $22.38 07/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003813363 Kowa Pharmaceuticals America, Inc. $23.65 01/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003813371 Kowa Pharmaceuticals America, Inc. $21.18 03/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003813379 Kowa Pharmaceuticals America, Inc. $20.56 04/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1019988227 Amgen Inc. $22.61 01/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1019988229 Amgen Inc. $28.61 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1019988231 Amgen Inc. $25.83 03/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1019988233 Amgen Inc. $13.92 06/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1024698079 Radius Health, Inc. $25.18 01/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1024698081 Radius Health, Inc. $29.32 02/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1024698083 Radius Health, Inc. $29.52 06/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1033905929 Astellas Pharma US Inc $24.63 02/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1033913630 Astellas Pharma US Inc $20.42 02/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034070179 Astellas Pharma US Inc $19.28 04/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034115165 Astellas Pharma US Inc $33.22 05/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034283361 Astellas Pharma US Inc $23.44 07/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034373037 Astellas Pharma US Inc $18.67 08/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1046789625 Organon LLC $19.25 03/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048628677 Merck Sharp & Dohme LLC $27.66 05/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.